Preparing a prescription drug monitoring program data set for research purposes

Pharmacoepidemiology and Drug Safety

Volumn 25, Issue 9, 2016, Pages 993-997

  O'Kane, Nicole ^a   Hallvik, Sara E ^a   Marino, Miguel ^b,c   Van Otterloo, Joshua ^d   Hildebran, Christi ^a   Leichtling, Gillian ^a   Deyo, Richard A ^b,c  

^a Acumentra Health   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OREGON HEALTH AUTHORITY   (United States)

Author keywords

data sources; diversion measurement; metrics; pharmacoepidemiology; prescription drug abuse; prescription drug monitoring program; prescription opioid

Indexed keywords

MORPHINE; OPIATE; PRESCRIPTION DRUG;

ARTICLE; DRUG RESEARCH; DRUG SURVEILLANCE PROGRAM; INFORMATION PROCESSING; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 84984914580     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.4039     Document Type: Article

References (8)

1. US Department of Health and Human Services, Behavioral Health Coordinating Committee. Addressing prescription drug abuse in the United States: current activities and future opportunities. 2013. http://www.cdc.gov/drugoverdose/pdf/hhs_prescription_drug_abuse_report_09.2013.pdf. Accessed 11 August 2015.
2. Haegerich TM, Paulozzi LJ, Manns BJ, et al. What we know and don't know about the impact of state policy and systems-level interventions on prescription drug overdose. Drug Alcohol Depend 2014; 145C: 34–47. doi:10.1016/j.drugalcdep.2014.10.001.
3. Centers for Disease Control and Prevention. Number of poisoning deaths involving opioid analgesics and other drugs or substances—United States, 1999–2010. MMWR Morb Mortal Wkly Rep 2013; 62(12): 234.
4. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010; 152(2): 85–92. doi:10.7326/0003-4819-152-2-201001190-00006.
5. Miller M, Barber CW, Leatherman S, et al. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA Intern Med 2015; 175(4): 608–615. doi:10.1001/jamainternmed.2014.8071.
6. National Center for Injury Prevention and Control. CDC Conversion Reference Table. A compilation of opioid analgesic formulations with morphine milligram equivalent conversion factors, 2014 version. Atlanta, GA: Centers for Disease Control and Prevention. http://www.pdmpassist.org/pdf/BJA_performance_measure_aid_MME_conversion.pdf. Accessed Conversion Reference Table.xlsx 15 September 2014.
7. US Food and Drug Administration. National Drug Code database file. http://www.fda.gov/Drugs/InformationOnDrugs/ucm142438.htm. Accessed 14 June 2014.
8. US Food and Drug Administration. National Drug Code database background information. http://www.fda.gov/drugs/developmentapprovalprocess/ucm070829. Accessed 29 April 2015.